论文部分内容阅读
目的:探讨米非司酮配伍米索前列醇在中期妊娠引产中的效果。方法:将100例14-27周自愿要求引产的正常妊娠孕妇平均分成对照组与实验组。对照组给予利凡诺尔羊膜腔注射,实验组予以米非司酮配伍米索前列醇,观察两组引产效果。结果:经比较,米非司酮配伍米索前列醇组较利凡诺尔羊膜腔注射组,引产率高,可减少引产时间、产后出血量、胎盘及胎膜的残留。结论:米非司酮配伍米索前列醇用于中期引产操作简单,安全可靠,值得应用和推广。
Objective: To investigate the effect of mifepristone and misoprostol in induction of labor during the second trimester pregnancy. Methods: A total of 100 normal pregnant women who required induction of labor at 14-27 weeks were divided equally into control group and experimental group. Control group was given rivanol amniotic cavity injection, the experimental group was given mifepristone with misoprostol, observed the effect of induction of labor in both groups. Results: By comparison, mifepristone with misoprostol group than rivanol amniotic cavity injection group, high induction rate, can reduce the induction of labor, postpartum hemorrhage, placental and fetal membrane residues. Conclusion: Mifepristone combined with misoprostol for mid-term induction of labor is simple, safe and reliable, which deserves application and promotion.